CureVac N.V. Made Headway
Thu, Jun 12, 2025 at 07:27 PM
CureVac N.V. (CVAC:NASDAQ) soared at $5.6, a gain of 37.6%. On Thu, Jun 12, 2025, CVAC:NASDAQ hit a New 2-Week High of $5.6. The stock got featured on our News Catalysts scanner on Thu, Jun 12, 2025 at 02:13 PM in the 'ACQUISITION' category. From Thu, May 29, 2025, the stock recorded 50.00% Up Days and 36.36% Green Days
About CureVac N.V. (CVAC:NASDAQ)
CureVac NV a clinical-stage biopharmaceutical company, developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people.
Top 10 Gainers:
- Greenlane Holdings, Inc. (GNLN:NASDAQ), 100%
- Creative Global Technology Holdings Limited (CGTL:NASDAQ), 98.29%
- Liminatus Pharma, Inc. (LIMN:NASDAQ), 82.81%
- Smart for Life, Inc. (SMFL:NASDAQ), 54.65%
- UroGen Pharma Ltd. (URGN:NASDAQ), 51.78%
- Signature Bank (SBNY:NASDAQ), 44.44%
- Distoken Acquisition Corporation (DIST:NASDAQ), 42.13%
- Sagimet Biosciences Inc. (SGMT:NASDAQ), 39.1%
- Klotho Neurosciences, Inc. (KLTO:NASDAQ), 37.93%
- CureVac N.V. (CVAC:NASDAQ), 37.59%